Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
1.060
-0.157 (-12.94%)
At close: Aug 20, 2026
Brainstorm Cell Therapeutics Employees
Brainstorm Cell Therapeutics had 19 employees as of March 31, 2026. The number of employees decreased by 10 or -34.48% compared to the same quarter last year.
Employees
19
Change
-10
Growth
-34.48%
Revenue / Employee
n/a
Profits / Employee
-$553,789
Market Cap
11.70M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Adaptimmune Therapeutics | 272 |
| Oncotelic Therapeutics | 43 |
| Zeo ScientifiX | 20 |
| Inhibitor Therapeutics | 8 |
| ZIVO Bioscience | 7 |
| Provectus Biopharmaceuticals | 6 |
| Anebulo Pharmaceuticals | 3 |
| Synlogic | 1 |
Brainstorm Cell Therapeutics News
- Just now - Brainstorm Cell Therapeutics Earnings release: Q2 2026 - Filings
- Just now - Brainstorm Cell Therapeutics Quarterly report: Q2 2026 - Filings
- 6 days ago - BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 23 days ago - BrainStorm Appoints Former FDA Associate Commissioner Peter J. Pitts as Executive Chairman - PRNewsWire
- 2 months ago - BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine - PRNewsWire
- 3 months ago - Lunai Bioworks and BrainStorm launch foundation for neurological diseases - TheFly
- 3 months ago - BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors - PRNewsWire
- 3 months ago - Brainstorm Cell Therapeutics Registration statement: Registration filing - Filings